On January 27-28, the VANGUARD general assembly took place in Innsbruck, Austria. Nineteen participants representing the consortium’s nine project partners gathered for a two-day program consisting of project updates, planning sessions, and discussions. The meeting was kindly organized by the
A new publication on Regulatory Challenges at the Intersection of Cellular and Medical Device Therapies in Europe: The Case of the Bioartificial Pancreas in Law, Technology and Humans. Abstract Regenerative medicine solutions for type 1 diabetes are a rapidly developing
VANGUARD partners have published a publication titled The Relevance of Advanced Therapy Medicinal Products in the Field of Transplantation and the Need for Academic Research Access: Overcoming Bottlenecks and Claiming a New Time as part of the Transplant International special
As part of the Transplant International special issue on The Future of Beta Cells Replacement in the Era of Regenerative Medicine and Organ Bioengineering, VANGUARD partners published a review article on Clinical Translation of Bio-Artificial Pancreas Therapies: Ethical, Legal and
On the 3rd and 4th of July, the cosmopolitan city of Milan, Italy, played host to the bi-annual project meeting of VANGUARD. The meeting was organised by Lorenzo Piemonti and his team from San Raffaele Hospital. The agenda was dense
A new VANGUARD article on Therapeutic potential of fetal liver cell transplantation in hemophilia A mice has recently been published in haematologica. The publication is available open access online: https://haematologica.org/article/view/haematol.2022.282001 Abstract Hemophilia A (HA) cell therapy approaches in pediatric individuals
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no. 874700